/PRNewswire/ EpiVario, Inc., a biotech company developing novel therapeutics for memory-related psychiatric disorders, today announced it has been awarded a.
For a design that extends shelf-lives of staple foods and improves crop seeding, Benedetto Marelli is the winner of the inaugural BioInnovation Institute & Science Prize for Innovation.
EpiVario Establishes Scientific Advisory Board
Share Article
EpiVario
Bringing deep expertise in the areas of neuroscience, psychology, and epigenetics, these individuals will help EpiVario with its ongoing research efforts to utilize novel medical and scientific discoveries for the development of therapeutics for memory- and addiction-related diseases. - Dr. Berger PHILADELPHIA (PRWEB) February 16, 2021
EpiVario, Inc., a preclinical stage drug discovery and development company, today announced the formation of a Scientific Advisory Board (SAB) comprised of leading experts in neuroscience, psychology, and epigenetics. The SAB will guide and advise the Company on the translation of core discoveries into the research and development of therapeutic approaches for memory-related psychiatric disorders, including PTSD, drug and alcohol use disorder, and Alzheimer’s disease.